1166508

Abraxis Bioscience, LLC — FEI 3006441852

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 6, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures